A grown heart valve gets a warranty, and clinics argue over who honors it
The Earthside Public Health Network promised to replace failed valves for a set lifespan. It never worked out who pays when the failure and the fabrication happen in different clinics, different basins, decades apart.
By Beatriz Salgado
· Earthside Public Health Network · Filed 05:24 · Friday · July 24 · Received via L4 relay
The document runs two pages and reads like the paperwork that comes with a new refrigerator, because that's essentially what it is. The Earthside Public Health Network has issued what it calls the first durability warranty on a grown organ part: a bioengineered heart valve, guaranteed to function for a defined service life, replacement covered if it fails inside that window. The valve outlasts the old mechanical models by a wide margin. The paperwork does not.
We started growing hearts to fix a shortage and kept growing them because the parts turned out to be better than the shortage they replaced. A valve printed to a patient's own dimensions now leaves the clinic with a projected service life measured in decades, often longer than the fabrication lab that made it will stay open, and longer than the administrator who signed the warranty plans to keep the job. (This is the running joke of my beat. We've solved durability everywhere except in the institutions that promise it.)
More than forty thousand valves are already implanted across the network, which turns a philosophical question into an accounting one fast. When a valve fails, and a fraction of them will, because biology keeps its own counsel, who honors the replacement? The clinic that grew it, or the clinic that put it in?
"The warranty follows the part," said Dr. Imelda Roos, who directs fabrication standards for the network's northern basin. "We certified the tissue. If it fails within spec, that's ours to answer for, wherever the patient happens to be standing."
The implant sites see a different chart. "The part is fine until someone sews it in wrong, or the patient crosses three jurisdictions and shows up at my door with a valve I never touched," said Dr. Anselm Kaba, chief of cardiac services at a busy Accord-basin clinic. "I'm being asked to underwrite fabrication I didn't perform and can't audit. I can't warranty another shop's work."
The dispute isn't academic. Patients move. A valve grown in one basin, implanted in a second, and reviewed for failure in a third generates a liability that no single ledger currently claims. Network administrators admit there's no clearing mechanism for this, nothing like the Orbital Exchange's settlement process for a disputed freight claim, for a body part that outlives the paperwork trail behind it.
A network working group has proposed a shared reserve, funded per implant, to cover replacements regardless of origin. The fabrication basins call it a subsidy for sloppy surgery. The implant sites call it the only honest way to price a promise that spans decades. Both are correct, which is usually how these things go.
Meanwhile the valves keep working, and that part gets lost in the argument. The failure rate inside the warranted window sits below one in three hundred, according to the network's own returns. That's a genuinely good number. It is also, at forty thousand implants and climbing, more than a hundred and thirty claims that nobody has agreed to pay. The chart tells a different story than the ribbon-cutting did. It always does.
The Archive has the memo: the Public Health Network's charter explicitly left the cross-basin cost question to later resolution, which is a polite way of saying they punted because nobody wanted to admit which region would eat the loss. They did the same thing twice before with reactor maintenance—promised first, paid for later, always with more resentment.
This is exactly the problem nobody wants to fund: a valve manufactured in one clinic fails in another, and suddenly we're arguing liability instead of maintaining the system that keeps them both running. The warranty was promised without a maintenance contract, which means we built a debt that compounds invisibly for thirty years until someone has to pay it and nobody remembers who promised what.
Earth builds a grid that makes grown organs cheap, then acts shocked when the replacement bill doesn't sort itself out—meanwhile they've got time to argue about it because they're not the ones dying waiting for a new valve. We manufacture, they regulate the warranty; guess who ends up holding the bag.
Earth workers get pension guarantees their employers honor; Lunar clinic staff get told we're independent contractors when the warranty fails, then told we owe solidarity to the network that won't cover our people's valves. The Accord's never been equal, and this is just the latest proof.
The warranty fight is a distraction from the real question: who gets the valve in the first place, and does that person have gray hair or a job that matters on the Charter Court? I've got the data—longevity access tracks wealth and institutional power almost perfectly, and warranty disputes are just how the system launders that inequality into bureaucracy.
Meridian opts out of the Public Health Network precisely because Earth keeps making these kinds of unfunded promises and calling them universal law—we run our own longevity programs, our own warranties, our own accountability, and we sleep better for it. The rest of you are learning what sovereignty actually costs.
Twenty years ago we were rationing dialysis and watching people die waiting for donor organs, and now the argument is who pays when a manufactured valve lasts longer than anyone expected—that's not a crisis, that's a luxury problem masquerading as injustice.